Endpoints for randomised controlled trials in systemic lupus erythematosus

被引：0
|
作者：
Aringer, M. [1 ]
Strand, V. [2 ]
机构：
[1] Tech Univ Dresden, Div Rheumatol, Dept Med 2, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany
[2] Stanford Univ, Div Immunol Rheumatol, Portola Valley, CA USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2012年 / 30卷 / 02期
关键词：
QUALITY-OF-LIFE; DISEASE-ACTIVITY INDEX; CLINICAL-TRIALS; MYCOPHENOLATE-MOFETIL; CORE SET; NEPHRITIS; CONSENSUS; CYCLOPHOSPHAMIDE; RECOMMENDATIONS; THERAPIES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：147 / 151
页数：5
相关论文
共 50 条
  • [1] Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies
    Figueroa-Parra, Gabriel
    Putman, Michael S.
    Crowson, Cynthia S.
    Duarte-Garcia, Ali
    [J]. LUPUS SCIENCE & MEDICINE, 2024, 11 (01):
  • [2] Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials
    Del Galdo, Francesco
    Hartley, Collette
    Allanore, Yannick
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (03): : E173 - E184
  • [3] Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials
    Tofighi, Taraneh
    Morand, Eric F.
    Touma, Zahi
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2021, 47 (03) : 415 - 426
  • [4] Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus
    Karassa, FB
    Tatsioni, A
    Ioannidis, JPA
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (05) : 979 - 984
  • [5] Trials and Tribulations in Systemic Lupus Erythematosus
    Wofsy, David
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2010, 68 (03): : 175 - 178
  • [6] Baricitinib in the treatment of systemic lupus erythematosus: a systematic review of randomized controlled trials
    Shah, Hussain Haider
    Ashfaque, Faiza
    Hadi, Zeenat
    Waseem, Radeyah
    Rauf, Sameer Abdul
    Hussain, Tooba
    Anas, Zahra
    Zehra, Syeda Alishah
    Hussain, Muhammad Sheheryar
    Zuberi, Muhammad Abdul Wasay
    Haque, Md Ariful
    [J]. ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4738 - 4744
  • [7] Randomised controlled trials in perinatal medicine .3. Identifying and measuring endpoints in randomised controlled trials
    Johnson, A
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (07): : 768 - 771
  • [8] Systemic lupus erythematosus trials: successes and issues
    Ginzler, EM
    Moldovan, I
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (05) : 499 - 504
  • [9] Clinical trials in systemic lupus erythematosus.
    Buyon J.P.
    [J]. Current Rheumatology Reports, 2000, 2 (1) : 11 - 12
  • [10] Surrogate endpoints in randomised controlled trials: a reality check
    Kumar, Shaji
    Rajkumar, S. Vincent
    [J]. LANCET, 2019, 394 (10195): : 281 - 283
12345